S
Spero Therapeutics (SPRO)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Spero Therapeutics (SPRO)
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. Its lead product candidate, tebipenem HBr (tebipenem pivoxil ... Read more
- USD2.90
- USD2.94
- USD2.90
- USD3.09
- 10.20%
- 45M
- 390.07k
- 8.65M
- 164M
- 0.51
- 119.60%
Stock News
4 hours ago
Dow Jones Futures: Tariffs In Focus After Trump Budget; Tesla Rival Uber Leads 5 Stocks In Buy Zones
Yahoo
5 hours ago
Happiness researcher shares his '90-second rule' to live a better, more fulfilled life—it helps when you're angry or upset
CNBC
5 hours ago
Retirees are flocking to these 10 U.S. states—No. 1 offers low taxes and sunny weather
CNBC
6 hours ago
Fast-casual restaurants lean on loyalty programs to offset consumer pullback
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
